Brind.

Praluent, a drug, has limited availability in China.

1 report, 1 independent Updated Aug 12

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

China Sanofi

Keep exploring

The entities involved

China
cultural region, ancient civilization, and nation in East Asia; mostly refers to the People's Republic of China in political situation and rarely refers to the Republic of China
- The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49
- The Middle Corridor, linking Central Asia and Europe, is gaining significance in regional trade and energy routes.Mon 17:06
Sanofi
company in Milan, Italy

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 12Investing.comSanofi halts Praluent supply in China due to limited availability Investing.com -- Sanofi (NASDAQ:SNY) announced on Tuesday that it has stopped supplying Praluent in China due to limited availability